4.5 Review

Combinatorial chemistry in drug discovery

Journal

CURRENT OPINION IN CHEMICAL BIOLOGY
Volume 38, Issue -, Pages 117-126

Publisher

ELSEVIER SCI LTD
DOI: 10.1016/j.cbpa.2017.03.017

Keywords

-

Funding

  1. National Institutes of Health [R21 CA135345, R01CA115483, R33CA196445, U01EB021230]

Ask authors/readers for more resources

Several combinatorial methods have been developed to create focused or diverse chemical libraries with a wide range of linear or macrocyclic chemical molecules: peptides, non-peptide oligomers, peptidomimetics, small-molecules, and natural product-like organic molecules. Each combinatorial approach has its own unique high-throughput screening and encoding strategy. In this article, we provide a brief overview of combinatorial chemistry in drug discovery with emphasis on recently developed new technologies for design, synthesis, screening and decoding of combinatorial library. Examples of successful application of combinatorial chemistry in hit discovery and lead optimization are given. The limitations and strengths of combinatorial chemistry are also briefly discussed. We are now in a better position to truly leverage the power of combinatorial technologies for the discovery and development of next-generation drugs.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.5
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available